• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA grants IND clearance for Allay’s trial of post-surgical pain treatment

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 13, 2024 at 10:52: AM
via The US Food and Drug Administration (FDA) has granted clearance to Allay Therapeutics’ investigational new drug (IND) application to initiate a Phase IIb clinical trial of ATX101, aimed at alleviating post-surgical pain in patients undergoing total knee replacement surgery.

article source
 




Similar threads

cafead
FDA grants IND clearance for Find’s Phase I chronic optic neuropathy trial
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Replies
0
Views
8
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Replies
0
Views
29
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Spinogenix’s ALS treatment trial
Replies
0
Views
65
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote